Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes

Cancer

Volumn 89, Issue 2, 2000, Pages 383-390

  Barakat, Richard R ^a   Federici, Mark G ^a   Saigo, Patricia E ^a   Robson, Mark E ^a   Offit, Kenneth ^a   Boyd, Jeff ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; BRCA1; Cell proliferation; ERBB 2; Hereditary; Morphology; Ovarian carcinoma; Ovary; P53; Premalignant

Indexed keywords

BRCA1 PROTEIN; CELL PROTEIN; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARIECTOMY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; APOPTOSIS; BRCA1 PROTEIN; CELL DEATH; CELL DIVISION; FEMALE; GENE EXPRESSION; GENES, BRCA1; GERM-LINE MUTATION; HETEROZYGOTE; HUMAN; KI-67 ANTIGEN; MIDDLE AGE; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034661872     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T     Document Type: Article

References (28)